Novo Nordisk: Demand drives another equipment boost in Clayton, US
Novo Nordisk is planning a $65m (€53m) production capacity expansion at its finished product site in North Carolina, to meet demand for diabetes and obesity medicines.
Archives for February 7, 2018
IQVIA awarded FDA contract to expand biologic safety monitoring
IQVIA has been contracted to expand the safety and efficacy monitoring of biologic products as part of a novel alliance with the US Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER).
EMA data transparency regulation upheld in ‘landmark rulings’
The EMA’s decision to release clinical trial documents requested in accordance with its Transparency Regulation has been upheld in court after companies filed to suspend the release in 2016.
US FDA warns Taiwan OTC maker over manufacturing violations
Failure to test ingredients’ identity in an over-the-counter drug product is one of the violations that landed Polaroisin International a US FDA warning letter.
News in Brief
Delmar to pump $46m into Canadian API plant
Italian API maker Delmar Chemicals will up production capacity at a plant in Quebec, Canada.
Nordic project takes ‘manufacturing-on-demand’ approach to future drugs
Nordic Universities will investigate 3D printing, electrospraying, and microfluidics in an industry supported collaboration aimed at revolutionising production in an age of personalised medicine.